Effects of flavonoids on the growth and cell cycle of cancer cells

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5229-5233

  Choi, Sang Un ^a   Ryu, Shi Yong ^a   Yoon, Seok Keun ^a   Jung, Noh Pal ^b   Park, Sung Hee ^a   Kim, Kwang Hee ^a   Choi, Eun Jung ^a   Lee, Chong Ock ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Cell cycle; Cytotoxicity; Flavonoids; Multidrug resistance; P glycoprotein

Indexed keywords

3 HYDROXYFLAVONE; 6 HYDROXYFLAVONE; 7 HYDROXYFLAVONE; BAICALEIN; CHRYSIN; F01; F02; F03; F04; F05; F06; F07; FLAVONE; FLAVONE DERIVATIVE; FLAVONOID; GLYCOPROTEIN P; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL KILLING; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; MITOSIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

CELL CYCLE; CELL DIVISION; FLAVONOIDS; HUMANS; TUMOR CELLS, CULTURED;

EID: 0033368232     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Middleton Ejr and Kandaswami C: The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: The flavonoids: Advances in research since 1986 (J. B. Harborne). London: Champman and Hall, 1993. pp619-652.
2. Shimoi K, Shen B, Toyokuni S, Mochizuki R, Furugori M and Kinae N: Protection by alpha G-rutin, a water soluble antioxidant flavonoid, against renal damage in mice treated with ferric nitrilotriacetate. Jpn J Cancer Res 88: 453-460, 1997.
3. Kuo SM: Dietary flavonoid and cancer prevention: evidence and potential mechanism. Crit Rev Oncog 8: 47-69, 1997.
4. Webster RP, Gawde MD and Bhattacharya RK: Protective effect of rutin, a flavonol glycoside, on the carcinogen-induced DNA damage and repair enzymes in rats. Cancer Lett 109: 185-191, 1996.
5. Kang TB and Liang NC: Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol 54: 1013-1018, 1997.
6. Lin JK, Chen YC, Huang YT and Lin-Shiau SY: Suppression of protein kinase C and unclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin. J Cell Biochem 28: 39-48, 1997.
7. Constantinou A, Mehta R and Runyan C: Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J Nat Prod 58: 217-225, 1995.
8. Meijer L: Chemical inhibitors of cycle-dependent kinases. Prog Cell Cycle Res 1: 351-363, 1995.
9. Sclafani RA and Schauer IE: Cell cycle control and cancer: lessons from lung cancer. J Investig Dermatol Symp Proc 1: 123-127, 1996.
10. Bai F, Matsui T, Ohtani-Fujita N, Matsukawa Y, Ding Y and Sakai T: Promoter activation and following induction of the p21/WAFI gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells. FEBS Lett 16: 61-64, 1998.
11. Choi S-U, Kim NY, Choi EJ, Kim KH, Lee JO. Establishment of doxorubicin-resistant subline derived from HCT15 human colorectal cancer cells. Arch Pharm Res 19: 342-7, 1996.
12. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112, 1990.
13. Choi S-U, Lee C-O, Kim K-H, Choi E-J, Park S-H, Shin H-S, Yoo S-E, Jung N-P and Lee B-H: Reversal of multidrug resistance by novel verapamil analogs in cancer cells. Anti- Cancer Drugs 9: 157-165, 1998.
14. Stewart N, Hicks GG, Paraskevas F and Mowat M: Evidence for a second cell cycle block at G2/M by p53. Oncogene 10: 109-115, 1995.
15. Lum BL, Gosland MP, Kaubisch S and Sikic BI: Molecular targets in oncology: Implications of the multidrug resistance gene. Pharmacotherapy 13: 88-109, 1993.
16. Endicott JA and Ling V: The biochemistry of P-glycoprotein mediated multidrug resistance. Annu Rev Biochem 58: 137-171, 1989.
17. Huberman JA: New views of the biochemistry of eucaryotic DNA replication revealed by aphidicolin, an unusual Inhibitor of DNA polymerase a. Cell 23: 647-648, 1981.
18. Kulp KS and Vulliet PR: Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells. Toxicol Appl Pharmacol 139: 356-364, 1996.
19. Watson PA, Hanauske-Abel HH, Flint A and Lalande M: Mimosine reversibly arrests cell cycle progression at the G1-S phase border. Cytometry 12: 242-246, 1991.
20. Zi Z, Grasso AW, Kung HJ and Agarwal R: A flavonoid antioxidant, silymarin, inhibits activation of erbBI signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. Cancer Res 58: 1920-1929, 1998.
21. Shen F and Weber G: Synergistic action of quercetin and genistein in human ovarian carcinoma cells. Oncol Res 9: 597-602, 1997.
22. Losiewicz MD, Carlson BA, Kaur G, Sausville EA and Worland PJ: Potent inhibition of CDC2 kinases activity by the falvonoid L86-8275. Biochem Biohpys Res Commun 201: 589-595, 1994.
23. Carlson BA, Dubay MM, Sausville EA, Bnzuela L and Worland PJ. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells. Cancer Res 56: 2973-2978, 1996.
24. Yoshida M, Yamamoto M and Nikaida T: Quercetin arrests human leukemic T-cells in late G 1 phase of the cell cycle. Cancer Res 52: 6676-6681, 1992.